Skip to main content
Top
Published in: International Journal of Hematology 4/2006

01-11-2006 | Case report

Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia

Authors: Satoshi Hashino, Fumie Fujisawa, Takeshi Kondo, Masahiro Imamura, Kazuya Sato, Yoshihiro Torimoto, Yutaka Kohgo, Keisuke Kimura, Hiroyuki Furukawa, Satoru Todo, Masahiro Asaka

Published in: International Journal of Hematology | Issue 4/2006

Login to get access
Metadata
Title
Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia
Authors
Satoshi Hashino
Fumie Fujisawa
Takeshi Kondo
Masahiro Imamura
Kazuya Sato
Yoshihiro Torimoto
Yutaka Kohgo
Keisuke Kimura
Hiroyuki Furukawa
Satoru Todo
Masahiro Asaka
Publication date
01-11-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06057

Other articles of this Issue 4/2006

International Journal of Hematology 4/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine